Welsh, González, and Negulescu share Lasker Award recognizing transformative treatments for people with cystic fibrosis

Tito) Gonzlez, and Paul Negulescu for the development of a novel class of drugs that nearly completely reverses the signs and symptoms of cystic fibrosis (CF) and slows disease progression.This award recognizes a translational tour-de-force, bridging the fundamental discovery of the molecular basis of CF in the 1980s to well-tolerated oral therapies that have revolutionized the lives of many thousands of people with CF in the 21st century.Conflict of interest: BDS holds US patent no.